東瑞製葯(02348.HK)簽訂產品合作協議
東瑞製葯(02348.HK)公布,與獨立第三方南京漢欣訂立合作協議,聯合進行產品包括︰Z2101、Z2102、Z2103、H2104、Z2105和Z2106的研發,並協助公司成為該等產品的上市許可持有人。
Z2101和Z2102是複雜注射劑,用於血液和造血系統以預防和治療出血。Z2103是一種合成多(月太)激素,用於治療骨質疏鬆症的注射劑。H2104、Z2105屬於促性腺激素釋放激素拮抗劑。Z2106是用於治療糖尿病的注射劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.